Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/c5fa3099-0c78-4d06-b183-b1c092ad6ce1/

FORTIS

Fortis Healthcare Limited
Chart
₹968.65
Latest Week 2026-06-05
HealthcareMedical Care FacilitiesMEGA
Snapshot 2026-06-07 · 0.0w · Fresh
0.43
OS Score
6.0%
Value
88.0%
Quality
87.0%
Momentum
8/9
F-Score
0.230
QV
StrategiesValueQualityMomentumCompositeInteractionsFactor AnalysisTrendsFundamentals
Strategy Eligibility
2 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
Noneyr
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
12-1 25%
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
6.0%ile
P/E
70.2×
P/S
8.0×
P/B
7.4×
E/P
0.0142
FCF Yield
0.009
EBITDA/EV
0.028
SH Yield
0.001
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
95.00000000
/100 — 1=cheapest
VC2 (Trending Value)
93.00000000
/100
VC3 (Buyback)
93.00000000
/100
P/E of 70.2x is premium-priced — the market is paying up for expected growth. VC2 score of 93.00000000/100 — expensive across all six composite measures.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
88.0%ile
ROE
0.105
ROA
0.065
Net Margin
0.114
Op Margin
0.179
GPA
0.319
Current
0.86
F-Score
8/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.173
Earn Growth
0.346
Stability
0.232
lower=better
Accruals
-0.035
lower=better
5yr Consist
Yes
F-Score of 8/9 indicates strong fundamental improvement across multiple dimensions.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
87.0%ile
6M Return
9.0%
12M Return
27.1%
12-1 Mom
24.9%
Risk-Adj
0.93
Vol 252d
26.7%
Vol 60d
60.1%
↑ Expanding
Max DD 12M
-27.3%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of 25% is very strong — a clear uptrend. Near-term vol (60%) is expanding vs long-term (27%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.43
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare · 160 peers
Sector Value %ile
12.4%
Sector Quality %ile
79.5%
P/E z-score
-0.05
P/B z-score
0.39
Sector Avg OS
43.7%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
NATCOPHARM NATCO Pharma Limited 98.0% 88.0% 87.0% 81.0%
LINCOLN Lincoln Pharmaceuticals Limited 97.0% 88.0% 80.0% 81.0%
UNIVPHOTO Universus Photo Imagings Limited 97.0% 86.0% 74.0% 94.0%
STAR Strides Pharma Science Limited 96.0% 73.0% 91.0% 91.0%
VENUSREM Venus Remedies Limited 96.0% 68.0% 94.0% 99.0%
HALEOSLABS Haleos Labs Limited 95.0% 82.0% 77.0% 81.0%
AUROPHARMA Aurobindo Pharma Limited 94.0% 71.0% 84.0% 87.0%
SAGILITY Sagility Limited 93.0% 76.0% 81.0% 76.0%
Factor Interactions
Quality Momentum — Expensive
Strong quality (88th) and momentum (87th) but expensive (6th value). Premium priced — watch for mean reversion.
Quality at a Premium
High quality (88th) but expensive (6th value). Upside may be limited without earnings growth.
Volatility Expanding
60-day vol (60%) significantly exceeds 252-day (27%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
F
16.0% avg (7 factors)
Quality
C
47.9% avg (7 factors)
Momentum
C
56.8% avg (4 factors)
Risk
B
72.1% avg (1 factors)
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.430—0—
Value %ile0.060—1—
Quality %ile0.880—1—
Momentum %ile0.870—1—
F-Score8.000—1—
Confidence0.939—1—
Volatility0.267—0—
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
70.20
Earnings Yield (E/P)
0.0142
Price / Sales
8.01
Price / Book
7.39
Price / Cash Flow
45.66
FCF Yield
0.9%
EBITDA / EV
2.8%
Sales Yield (1/P·S)
0.1198
Shareholder Yield
Div + net buyback / mktcap
0.1%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
10.5%
Return on Assets
6.5%
Net Margin
11.4%
Operating Margin
17.9%
Gross Profit / Assets
Novy-Marx GPA
31.9%
Current Ratio
0.86
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.035
MomentumPrice trend strength over different horizons
6M Return
9.0%
12M Return
27.1%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
24.9%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
0.93
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
17.3%
Earnings Growth (YoY)
34.6%
Earnings Stability (CV)
Lower = more stable
0.232
5yr Consistent
EPS up every year for 5 years
Yes
Piotroski F-Score
8
Dividend Yield
0.1%
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
95
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
93
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
93
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity